Author:
El-Lebedy Dalia,Kafoury Mona,Abd-El Haleem Dalia,Ibrahim Alshaymaa,Awadallah Eman,Ashmawy Ingy
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference45 articles.
1. Diabetes Action Now. An Initiative of the World Health Organization and the International Diabetes Federation 2004 [http://www.who.int/diabetes/actionnow/en/DANbooklet.pdf], Diabetes Action Now. An Initiative of the World Health Organization and the International Diabetes Federation 2004 [
http://www.who.int/diabetes/actionnow/en/DANbooklet.pdf
]
2. Garber JA: Attenuating CV, risk factors in patients with diabetes: clinical evidence to clinical practice. Diabetes Obesity Metab 2002, 4(suppl 1):5–12. 10.1046/j.1462-8902.2001.00038.x
3. Chaudhary R, Likidlilid A, Thavatchai Peerapatdit T, Damras Tresukosol D, Srisuma S, Ratanamaneechat S, Sriratanasathavorn C: Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovasc Diabetol 2012, 11: 36–47. 10.1186/1475-2840-11-36
4. Sahin I: HDL-C as a new therapeutic target in the treatment of dyslipidemia. Med Sci 2012, 1(2):141–149. 10.5455/medscience.2012.01.141-149
5. Guo ZG, Li C, Zhong JK, Tu Y, Xie D: Laboratory investigation of dysfunctional HDL. Chem Phys Lipids 2012, 165(1):32–37. 10.1016/j.chemphyslip.2011.10.005
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献